Sponsor Pipeline

Jiangsu Famous Medical Technology Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
1
Recruiting
1
Phase 3
3
Disease Areas
Active Trials by Phase
Phase 4
1
Phase 3
1
Not specified
4
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06613373 An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy… Breast Cancer Not Yet Recruiting
Phase 3
NCT05709249 Xian-Lian-Jie-Du Optimization Decoction As an Adjuvant Treatment for Prevention of… Colon Cancer Recruiting
Not specified
NCT06136026 Integrated Chinese and Western Medicine Specialized Disease Cohort for Colorectal Cancer Colorectal Cancer Not Yet Recruiting
NCT06537674 Pyrotinib Combined With Trastuzumab Subcutaneously Compared Intravenous Administration in… HER2+ Breast Cancer Not Yet Recruiting
NCT07123116 Shenbai Granules for Preventing Recurrence of Low-Risk Colorectal Adenomas Colorectal Adenoma Not Yet Recruiting
NCT07129499 Shenbai Granules for Preventing Malignant Transformation of High-risk Colorectal Adenomas Colorectal Adenoma Not Yet Recruiting
Disease Areas
Get alerts when Jiangsu Famous Medical Technology Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free